Literature DB >> 31380848

Delivery of Antibodies into the Murine Brain via Convection-enhanced Delivery.

Michal Beffinger1, Linda Schellhammer1, Stanislav Pantelyushin1, Johannes Vom Berg2.   

Abstract

Convection-enhanced delivery (CED) is a neurosurgical technique enabling effective perfusion of large brain volumes using a catheter system. Such an approach provides a safe delivery method by-passing the blood brain barrier (BBB), thus allowing treatment with therapeutics with poor BBB-permeability or those for which systemic exposure is not desired, e.g., due to toxicity. CED requires optimization of the catheter design, injection protocol, and properties of the infusate. With this protocol we describe how to perform CED of a solution containing up to 20 µg of an antibody into the caudate putamen of mice. It describes preparation of step catheters, testing them in vitro and performing the CED in mice using a ramping injection program. The protocol can be readily adjusted for other infusion volumes and can be used for injecting various tracers or pharmacologically active or inactive substances, including chemotherapeutics, cytokines, viral particles, and liposomes.

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 31380848     DOI: 10.3791/59675

Source DB:  PubMed          Journal:  J Vis Exp        ISSN: 1940-087X            Impact factor:   1.355


  4 in total

1.  IL-13Rα2 Status Predicts GB-13 (IL13.E13K-PE4E) Efficacy in High-Grade Glioma.

Authors:  Julian S Rechberger; Kendra A Porath; Liang Zhang; Cody L Nesvick; Randy S Schrecengost; Jann N Sarkaria; David J Daniels
Journal:  Pharmaceutics       Date:  2022-04-24       Impact factor: 6.525

2.  Evaluating infusate parameters for direct drug delivery to the brainstem: a comparative study of convection-enhanced delivery versus osmotic pump delivery.

Authors:  Julian S Rechberger; Erica A Power; Victor M Lu; Liang Zhang; Jann N Sarkaria; David J Daniels
Journal:  Neurosurg Focus       Date:  2020-01-01       Impact factor: 4.047

3.  Convection enhanced delivery of EGFR targeting antibody-drug conjugates Serclutamab talirine and Depatux-M in glioblastoma patient-derived xenografts.

Authors:  Kendra A Porath; Michael S Regan; Jessica I Griffith; Sonia Jain; Sylwia A Stopka; Danielle M Burgenske; Katrina K Bakken; Brett L Carlson; Paul A Decker; Rachael A Vaubel; Sonja Dragojevic; Ann C Mladek; Margaret A Connors; Zeng Hu; Lihong He; Gaspar J Kitange; Shiv K Gupta; Thomas M Feldsien; Didier R Lefebvre; Nathalie Y R Agar; Jeanette E Eckel-Passow; Edward B Reilly; William F Elmquist; Jann N Sarkaria
Journal:  Neurooncol Adv       Date:  2022-08-24

4.  Enzymatic Dissociation Induces Transcriptional and Proteotype Bias in Brain Cell Populations.

Authors:  Daniele Mattei; Andranik Ivanov; Marc van Oostrum; Stanislav Pantelyushin; Juliet Richetto; Flavia Mueller; Michal Beffinger; Linda Schellhammer; Johannes Vom Berg; Bernd Wollscheid; Dieter Beule; Rosa Chiara Paolicelli; Urs Meyer
Journal:  Int J Mol Sci       Date:  2020-10-26       Impact factor: 5.923

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.